Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread

Goutham Narla, Analisa Difeo, Shen Yao, Asoka Banno, Eldad Hod, Helen L. Reeves, Rui F. Qiao, Olga Camacho-Vanegas, Alice Levine, Alexander Kirschenbaum, Andrew M. Chan, Scott L. Friedman, John A. Martignetti

Research output: Contribution to journalArticlepeer-review

134 Scopus citations

Abstract

Prostate cancer is a leading cause of cancer death in men. Risk prognostication, treatment stratification, and the development of rational therapeutic strategies lag because the molecular mechanisms underlying the initiation and progression from primary to metastatic disease are unknown. Multiple lines of evidence now suggest that KLF6 is a key prostate cancer tumor suppressor gene including loss and/or mutation in prostate cancer tumors and cell lines and decreased KLF6 expression levels in recurrent prostate cancer samples. Most recently, we identified a common KLF6 germ line single nucleotide polymorphism that is associated with an increased relative risk of prostate cancer and the increased production of three alternatively spliced, dominant-negative KLF6 isoforms. Here we show that although wild-type KLF6 (wtKLF6) acts as a classic tumor suppressor, the single nucleotide polymorphism-increased splice isoform, KLF6 SV1, displays a markedly opposite effect on cell proliferation, colony formation, and invasion. In addition, whereas wtKLF6 knockdown increases tumor growth in nude mice >2-fold, short interfering RNA-mediated KLF6 SV1 inhibition reduces growth by ∼50% and decreases the expression of a number of growth- and angiogenesis-related proteins. Together, these findings begin to highlight a dynamic and functional antagonism between wtKLF6 and its splice variant KLF6 SV1 in tumor growth and dissemination.

Original languageEnglish
Pages (from-to)5761-5768
Number of pages8
JournalCancer Research
Volume65
Issue number13
DOIs
StatePublished - 1 Jul 2005

Fingerprint

Dive into the research topics of 'Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread'. Together they form a unique fingerprint.

Cite this